MedTrace Logo

Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.

NCT00141128 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2011-06-01

No results posted yet for this study

Summary

SS-RBX will be used to evaluate pharmacodynamic changes in urethral function using a novel methodology

Conditions

  • Urinary Incontinence, Stress

Interventions

DRUG

SS-RBX

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Completion
2006-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00141128 on ClinicalTrials.gov